Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BANDAGIST-CENTRET, ORTOPÆDISKE BANDAGERIER OG SKOMAGERIER A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   0.6% 5.8% 2.6% 2.6% 0.7% 0.4% 3.7% 3.6%   Credit score (0-100)   98 40 60 60 94 100 52 52   Credit rating   AA BBB BBB BBB AA AAA BBB BBB   Credit limit (kDKK)   2,471.9 0.0 0.1 0.0 2,738.1 3,310.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   46,215 38,424 44,500 41,441 45,446 46,280 0.0 0.0   EBITDA   6,473 -2,850 7,745 2,970 8,785 9,448 0.0 0.0   EBIT   3,587 -2,850 7,745 2,970 6,422 7,195 0.0 0.0   Pre-tax profit (PTP)   2,721.5 -2,832.0 5,867.0 2,379.0 6,245.0 7,063.5 0.0 0.0   Net earnings   2,115.3 -2,832.0 5,867.0 2,379.0 4,870.7 5,214.7 0.0 0.0   Pre-tax profit without non-rec. items   2,721 -2,850 7,745 2,970 6,245 7,064 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   22,506 0.0 0.0 0.0 2,020 1,701 0.0 0.0   Shareholders equity total   14,395 11,124 11,130 10,508 15,379 17,594 12,594 12,594   Interest-bearing liabilities   21,376 0.0 0.0 0.0 937 1,906 0.0 0.0   Balance sheet total (assets)   54,982 46,673 34,430 36,663 35,216 34,056 12,594 12,594   Net Debt   21,284 0.0 0.0 0.0 -3,327 -3,992 -6,935 -6,935     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   46,215 38,424 44,500 41,441 45,446 46,280 0.0 0.0   Gross profit growth   2.2% -16.9% 15.8% -6.9% 9.7% 1.8% -100.0% 0.0%   Employees   72 71 65 63 66 66 0 0   Employee growth %   -10.0% -1.4% -8.5% -3.1% 4.8% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   54,982 46,673 34,430 36,663 35,216 34,056 12,594 12,594   Balance sheet change%   0.2% -15.1% -26.2% 6.5% -3.9% -3.3% -63.0% 0.0%   Added value   6,473.4 -2,850.0 7,745.0 2,970.0 6,421.7 9,447.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -3,413 -32,842 0 0 6,672 -3,927 -1,701 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.8% -7.4% 17.4% 7.2% 14.1% 15.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.6% -5.6% 19.1% 8.4% 17.9% 20.9% 0.0% 0.0%   ROI %   8.4% -6.4% 19.1% 8.4% 23.7% 37.5% 0.0% 0.0%   ROE %   13.7% -22.2% 52.7% 22.0% 37.6% 31.6% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   26.2% 100.0% 100.0% 100.0% 43.7% 51.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   328.8% 0.0% 0.0% 0.0% -37.9% -42.2% 0.0% 0.0%   Gearing %   148.5% 0.0% 0.0% 0.0% 6.1% 10.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.4% 0.0% 0.0% 0.0% 41.2% 11.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.6 0.0 0.0 0.0 1.4 1.7 0.0 0.0   Current Ratio   0.9 0.0 0.0 0.0 1.8 2.1 0.0 0.0   Cash and cash equivalent   91.7 0.0 0.0 0.0 4,264.2 5,897.7 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,902.1 0.0 0.0 0.0 10,600.1 12,929.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   90 -40 119 47 97 143 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   90 -40 119 47 133 143 0 0   EBIT / employee   50 -40 119 47 97 109 0 0   Net earnings / employee   29 -40 90 38 74 79 0 0